{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:32:53Z","timestamp":1762003973829,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.transci.2018.02.012","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T08:05:50Z","timestamp":1519113950000},"page":"27-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study"],"prefix":"10.1016","volume":"57","author":[{"given":"Emre","family":"Tekg\u00fcnd\u00fcz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Ali","family":"Erkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilhami","family":"Kiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Hakan","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leylagul","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inci","family":"Alacacioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guven","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Ozarslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Kuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulden","family":"Sincan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozan","family":"Salim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Namdaroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Karakus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volkan","family":"Karakus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi","family":"Altuntas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsum","family":"Ozet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismet","family":"Aydogdu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahap","family":"Okan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahsan","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esra","family":"Yildizhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gokhan","family":"Ozgur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman Ilhami","family":"Ozcebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahriye","family":"Payzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seval","family":"Akpinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Demirkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.transci.2018.02.012_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12959-016-0114-0","article-title":"Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome","volume":"14","author":"Shen","year":"2016","journal-title":"Thromb J"},{"issue":"4","key":"10.1016\/j.transci.2018.02.012_bib0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/1744-9987.12535","article-title":"At the cross section of thrombotic microangiopathy and atypical hemolytic uremic syndrome: a narrative review of differential diagnostics and a problematization of nomenclature","volume":"21","author":"\u00c5kesson","year":"2017","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transci.2018.02.012_bib0015","first-page":"216","article-title":"Atypical hemolytic uremic syndrome: differential diagnosis from TTP\/HUS and management","volume":"31","author":"Yenerel","year":"2014","journal-title":"Turk J Hematol"},{"issue":"2","key":"10.1016\/j.transci.2018.02.012_bib0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/ajcp\/aqv086","article-title":"Pathology consultation on the diagnosis and treatment of thrombotic microangiopathies (TMAs)","volume":"145","author":"Williams","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.transci.2018.02.012_bib0025","first-page":"2","article-title":"Atypical hemolytic uremic syndrome (aHUS): essential aspect of an accurate diagnosis","volume":"14","author":"Laurence","year":"2016","journal-title":"Clin Adv Hematol Oncol"},{"issue":"3","key":"10.1016\/j.transci.2018.02.012_bib0030","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jca.21302","article-title":"Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research","volume":"29","author":"Sarode","year":"2014","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.transci.2018.02.012_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.transci.2018.02.012_bib0040","first-page":"539","article-title":"The global aHUS registry: methodology and initial patient characteristics","volume":"91","author":"Licht","year":"2015","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.transci.2018.02.012_bib0045","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"Coppo","year":"2010","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.transci.2018.02.012_bib0050","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.transci.2018.02.012_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imj.12935","article-title":"Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP\/thrombotic microangiopathy registry","volume":"46","author":"Blombery","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/j.transci.2018.02.012_bib0060","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bjh.13658","article-title":"Impact of severe ADAMTS13 deficiency on clinical presentation and outcome in patients with thrombotic microangiopathies: the experience of the Harvard TMA research collaborative","volume":"171","author":"Bendapudi","year":"2015","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.transci.2018.02.012_bib0065","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/bjh.13654","article-title":"The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry","volume":"171","author":"Hassan","year":"2015","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.transci.2018.02.012_bib0070","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/jca.21437","article-title":"The thrombotic microangiopathy registry of North America: a United States multi-institutional TMA network","volume":"31","author":"Metjian","year":"2016","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.transci.2018.02.012_bib0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.hoc.2015.02.002","article-title":"Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome","volume":"29","author":"Sperati","year":"2015","journal-title":"Hematol Oncol Clin N Am"},{"issue":"2","key":"10.1016\/j.transci.2018.02.012_bib0080","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.chest.2017.03.055","article-title":"Expert statements on the standard of care in critically ill adult patients with atypical hemolytic uremic syndrome","volume":"152","author":"Azoulay","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.transci.2018.02.012_bib0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2018.02.012_bib0090","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transci.2018.02.012_bib0095","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1182\/blood-2013-11-516237","article-title":"How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2018.02.012_bib0100","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0037-1603100","article-title":"Clinical scoring systems in thrombotic microangiopathies","volume":"43","author":"Bendapudi","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.transci.2018.02.012_bib0105","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/asheducation-2016.1.217","article-title":"Atypical hemolytic uremic syndrome","volume":"2016","author":"Afshar-Kharghan","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"24","key":"10.1016\/j.transci.2018.02.012_bib0110","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.transci.2018.02.012_bib0115","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1182\/blood-2015-02-629683","article-title":"Modified Ham test for atypical hemolytic uremic syndrome","volume":"125","author":"Gavriilaki","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.transci.2018.02.012_bib0120","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/ckj\/sfx081","article-title":"Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea","volume":"10","author":"Brocklebank","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.transci.2018.02.012_bib0125","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ndt\/gfw453","article-title":"Eculizumab in secondary atypical haemolytic ureamic syndrome","volume":"32","author":"Cavero","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.transci.2018.02.012_bib0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood-2017-02-770214","article-title":"Eculizumab cessation in atypical hemolytic uremic syndrome","volume":"130","author":"Merrill","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.transci.2018.02.012_bib0135","first-page":"310","article-title":"Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic ureamic syndrome","volume":"10","author":"Macia","year":"2017","journal-title":"Clin Kidney J"},{"issue":"10","key":"10.1016\/j.transci.2018.02.012_bib0140","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3346\/jkms.2016.31.10.1516","article-title":"Clinical practice guidelines for the management of atypical hemolytic uremic syndrome in Korea","volume":"31","author":"Cheong","year":"2016","journal-title":"J Korean Med Sci"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218300466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050218300466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T05:38:57Z","timestamp":1570772337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050218300466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1473050218300466"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2018.02.012","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2018.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}